The evaluated biomarkers included the accumulation of oncoprotein p53 [22]–[24] and tumour proliferation index given by Ki-67 overexpression [26]–[28], two events associated with the aggressiveness of urothelial bladder cancer. This evidence concerns the gene TP53 and neoplasm.